检索结果 - Georgios Adamis

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    ACTIVATE-2: A DOUBLE-BLIND RANDOMIZED TRIAL OF BCG VACCINATION AGAINST COVID19 IN INDIVIDUALS AT RISK

    ACTIVATE-2: A DOUBLE-BLIND RANDOMIZED TRIAL OF BCG VACCINATION AGAINST COVID19 IN INDIVIDUALS AT RISK 由 Μαρία Τσιλικά, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ιlias Papanikolaou, Κimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyphallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G. Netea, Evangelos J. Giamarellos‐Bourboulis

    出版 2021
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  2. 2
    ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk

    ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk 由 Μαρία Τσιλικά, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ιlias Papanikolaou, Κimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyphallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G. Netea, Evangelos J. Giamarellos‐Bourboulis

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

    Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 由 Evdoxia Kyriazopoulou, Garyphallia Poulakou, Haralampos Milionis, Symeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, Archontoula Fragkou, Aggeliki Rapti, Christina Damoulari, Massimo Fantoni, Ioannis Kalomenidis, Georgios Chrysos, Andrea Angheben, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Μαρία Τσιλικά, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Evangelos Kostis, Lorenzo Dagna, Panagiotis Koufargyris, Katerina Dimakou, Spyridon Savvanis, Glykeria Tzatzagou, Maria Chini, Giulio Cavalli, Matteo Bassetti, Konstantina Katrini, Vasilios Kotsis, George Tsoukalas, Carlo Selmi, Ioannis A. Bliziotis, Michael Samarkos, Michael Doumas, Sofia Ira Ktena, Aikaterini Masgala, Ιlias Papanikolaou, Maria Kosmidou, Dimitra-Melia Myrodia, Aikaterini Argyraki, Chiara Simona Cardellino, Katerina Koliakou, Eleni-Ioanna Katsigianni, Vassiliki Rapti, Efthymia Giannitsioti, Antonella Cingolani, Styliani Micha, Karolina Akinosoglou, Orestis Liatsis-Douvitsas, Styliani Symbardi, Nikolaos Gatselis, Maria Mouktaroudi, Giuseppe Ippolito, Eleni Florou, Antigone Kotsaki, Mihai G. Netea, Jesper Eugen‐Olsen, Miltiades Kyprianou, Periklis Panagopoulos, George Ν. Dalekos, Evangelos J. Giamarellos‐Bourboulis

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: